Cargando…

Predictive Factors of Local Recurrence after Colorectal Cancer Liver Metastases Thermal Ablation

Background: Identify risk factors for local recurrence (LR) after radiofrequency (RFA) and microwave (MWA) thermoablations (TA) of colorectal cancer liver metastases (CCLM). Methods: Uni- (Pearson’s Chi(2) test, Fisher’s exact test, Wilcoxon test) and multivariate analyses (LASSO logistic regression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Odet, Julien, Pellegrinelli, Julie, Varbedian, Olivier, Truntzer, Caroline, Midulla, Marco, Ghiringhelli, François, Orry, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058972/ https://www.ncbi.nlm.nih.gov/pubmed/36976117 http://dx.doi.org/10.3390/jimaging9030066

Ejemplares similares

Percutaneous Implantation of a Microcatheter-Port System for Hepatic Arterial Infusion Chemotherapy of Unresectable Liver Tumors: Technical Feasibility, Functionality, and Complications
por: Chevallier, Olivier, et al.
Publicado: (2021)

Predictive Factors for Local Recurrence after Intraoperative Microwave Ablation for Colorectal Liver Metastases
por: Wada, Yoshiyuki, et al.
Publicado: (2022)

Role of Thermal Ablation in Colorectal Cancer Lung Metastases
por: Delpla, Alexandre, et al.
Publicado: (2021)

Genomic biomarker of checkpoint efficacy, highways for precision medicine in lung cancer
por: Ghiringhelli, Francois, et al.
Publicado: (2018)

Recurrent Colorectal Liver Metastases in the Liver Remnant After Major Liver Surgery—IRE as a Salvage Local Treatment When Resection and Thermal Ablation are Unsuitable
por: Hitpass, Lea, et al.
Publicado: (2021)

Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer
por: Yang, Po-Chih, et al.
Publicado: (2016)

Thermal Ablation Compared to Partial Hepatectomy for Recurrent Colorectal Liver Metastases: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study
por: Dijkstra, Madelon, et al.
Publicado: (2021)

Cell lines and immune classification of glioblastoma define patient’s prognosis
por: Klopfenstein, Quentin, et al.
Publicado: (2019)

Biopsy and Margins Optimize Outcomes after Thermal Ablation of Colorectal Liver Metastases
por: Vasiniotis Kamarinos, Nikiforos, et al.
Publicado: (2022)

Utility of exome sequencing in routine care for metastatic colorectal cancer
por: D'Agay, Melchior De Giraud, et al.
Publicado: (2021)

Implications of RAS Mutations on Oncological Outcomes of Surgical Resection and Thermal Ablation Techniques in the Treatment of Colorectal Liver Metastases
por: Rhaiem, Rami, et al.
Publicado: (2022)

Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases
por: Laimer, Gregor, et al.
Publicado: (2021)

Using Exome Sequencing to Improve Prediction of FOLFIRINOX First Efficacy for Pancreatic Adenocarcinoma
por: Lecuelle, Julie, et al.
Publicado: (2021)

FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short report
por: Roussot, Nicolas, et al.
Publicado: (2023)

Transarterial Radioembolization of Hepatocellular Carcinoma, Liver-Dominant Hepatic Colorectal Cancer Metastases, and Cholangiocarcinoma Using Yttrium90 Microspheres: Eight-Year Single-Center Real-Life Experience
por: Pellegrinelli, Julie, et al.
Publicado: (2021)

Correction to: Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases
por: Laimer, Gregor, et al.
Publicado: (2021)

Safety and efficacy of a docetaxel-5FU-oxaliplatin regimen with or without trastuzumab in neoadjuvant treatment of localized gastric or gastroesophageal junction cancer: A retrospective study
por: Basso, Valeria, et al.
Publicado: (2019)

RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer
por: Ledys, Fanny, et al.
Publicado: (2018)

Cost-Effectiveness Analysis of Local Ablation and Surgery for Liver Metastases of Oligometastatic Colorectal Cancer
por: Froelich, Matthias F., et al.
Publicado: (2021)

Survival Evidence of Local Control for Colorectal Cancer Liver Metastases by Hepatectomy and/or Radiofrequency Ablation
por: Canseco, Lariza Marie, et al.
Publicado: (2023)

Is microwave ablation therapy as effective as colorectal liver metastases in noncolorectal liver metastases?
por: DANIŞAN, Gürkan, et al.
Publicado: (2022)

Clinical analysis of ultrasound-guided radiofrequency ablation for recurrent colorectal liver metastases after hepatectomy
por: Fan, Xiao-xiang, et al.
Publicado: (2020)

Microwave ablation of colorectal liver metastases: Impact of a 10-mm safety margin on local recurrence in a tertiary care hospital
por: Ausania, Fabio, et al.
Publicado: (2021)

Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases
por: Wensink, G E, et al.
Publicado: (2023)

Impact of Systemic Therapy and Recurrence Pattern on Survival Outcome after Radiofrequency Ablation for Colorectal Liver Metastases
por: Stang, Axel, et al.
Publicado: (2016)

Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the interventional oncology sans frontières meeting 2013
por: Gillams, Alice, et al.
Publicado: (2015)

Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy
por: Ballot, Elise, et al.
Publicado: (2020)

How Compatible Are Immune Checkpoint Inhibitors and Thermal Ablation for Liver Metastases?
por: Minami, Yasunori, et al.
Publicado: (2022)

Liver resection surgery versus thermal ablation for colorectal LiVer MetAstases (LAVA): study protocol for a randomised controlled trial
por: Gurusamy, Kurinchi, et al.
Publicado: (2018)

Thermic ablation with RF of liver metastases from colorectal cancer
por: Azzarello, Guido, et al.
Publicado: (2009)

Bevacizumab Efficacy in Metastatic Colorectal Cancer is Dependent on Primary Tumor Resection
por: Ghiringhelli, Francois, et al.
Publicado: (2014)

Complications after Thermal Ablation of Hepatocellular Carcinoma and Liver Metastases: Imaging Findings
por: De Muzio, Federica, et al.
Publicado: (2022)

Thermal ablation of mucosal defect margins to prevent local recurrence of large colorectal polyps: a systematic review and meta-analysis
por: Meulen, Lonne W.T., et al.
Publicado: (2022)

3D Quantitative Ablation Margins for Prediction of Ablation Site Recurrence After Stereotactic Image-Guided Microwave Ablation of Colorectal Liver Metastases: A Multicenter Study
por: Ruiter, Simeon J. S., et al.
Publicado: (2021)

Microwave Ablation and Immune Activation in the Treatment of Recurrent Colorectal Lung Metastases: A Case Report
por: Bäcklund, Magnus, et al.
Publicado: (2017)

3D margin assessment predicts local tumor progression after ablation of colorectal cancer liver metastases
por: Kamarinos, Nikiforos Vasiniotis, et al.
Publicado: (2022)

Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy
por: Buisman, Florian E., et al.
Publicado: (2020)

Thermal Ablation versus Stereotactic Ablative Body Radiotherapy to Treat Unresectable Colorectal Liver Metastases: A Comparative Analysis from the Prospective Amsterdam CORE Registry
por: Nieuwenhuizen, Sanne, et al.
Publicado: (2021)

Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma
por: Aarnink, Anne, et al.
Publicado: (2018)

Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer
por: Galland, Loïck, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h2p1c1v14e231i3s69l08aurea